NCT01483833

Efficacy Study of Iferanserin to Treat Hemorrhoids

Protocol for the Study of the Effects of S-MPEC (Iferanserin) in Patients With Hemorrhoids

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 121 (actual)
• Sponsor: Ventrus Biosciences, Inc · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To evaluate the safety and efficacy of topical 0.5% S-MPEC cream vs. placebo cream (applied twice daily for 14 days) in the treatment of Grade I - III hemorrhoids.

Conditions

• Hemorrhoids

Interventions

Type	Name	Description
DRUG	Iferanserin	Iferanserin 0.5% ointment applied intra-anally twice daily for 14 days
DRUG	Placebo	Placebo ointment applied intra-anally twice daily for 14 days

Timeline

• Start date: 2001-09-01
• Primary completion: 2002-08-01
• Completion: 2002-08-01
• First posted: 2011-12-01
• Last updated: 2013-08-21

Locations

1 site across 1 country: Germany